Kensey Nash has received FDA clearance for the firm’s Meso Biomatrix porcine-based mesothelium extracellular matrix. Developed for use during soft tissue repair to reinforce weak regions, the Meso Biomatrix is manufactured using Kensey Nash’s Optrix method of clearing porcine tissue of cells, viruses, and just about anything else that’s not the structural tissue matrix.
Kensey Nash Corporation’s Meso BioMatrix™ Surgical Patch is a resorbable porcine mesothelium-derived surgical mesh intended for reinforcement of soft tissues. The Meso BioMatrix Surgical Patch is a porcine-based mesothelium extracellular matrix designed to reinforce soft tissues where weakness exists in patients requiring soft tissue repair. Medeor™ Matrix, Kensey Nash’s previously cleared porcine dermis derived surgical mesh, and the Meso BioMatrix product are manufactured using Kensey Nash’s proprietary Optrix™ process, which gently disinfects tissues, inactivates viruses and removes cells while preserving extracellular matrix components and structure.
Meso BioMatrix Surgical Patch is a strong, flexible patch that can be sutured over a soft tissue repair site in order to reinforce the tissue during healing or to repair a damaged soft tissue. The patch will act as a temporary scaffold, preventing gaps from occurring between the juxtaposed tissues, and is eventually resorbed by the body and replaced by the patient’s own soft tissues.